استفاده از دستگاه های خشک کن دست توصیه نمی شود هوای ناپاک در هفته هوای پاک استنشاق کنید! خواب رفتن دست ها از پیشگیری تا درمان کسب ربته دوم در رتبه بندی جهانی 4ICU

استفاده از دستگاه های خشک کن دست توصیه نمی شود

نتايج حاصله از تحقيقات انجام شده حاکی از آن است که افرادی که در مقابل خشک کن های برقی قرار می گیرند احتمالا بیشتر در معرض ابتلا به باکتری هایی هستند که این هوای داغ به سوی آنها گسیل می دارد.به گزارش وب دا ،…

ادامه مطلب

هوای ناپاک در هفته هوای پاک استنشاق کنید!

ادادشت روز: 29  دي الي پنج بهمن هفته هواي پاک نامگذاري شده است ، نامگذاري نمادين اين هفته به معني آن است که به فکر آسمان شهرمان باشيم و از آن غافل نشويم .به گزارش وب دا ، اين روزها قصه آلودگي هواي شهرهاي بزرگ…

ادامه مطلب

خواب رفتن دست ها از پیشگیری تا درمان

اکنون شده وقتی طولانی‌مدت گوشی تلفن یا چادرتون را نگه داشته‌ايد، احساس کنید دستتان خواب رفته و یا سنگین شده است؟! یا صبح‌ها که از خواب بیدار می‌شوید و حتی شب‌ها هنگام خواب، احساس سوزن‌سوزن و بي‌حس شدن دست‌ها بطوري که نتوانید براحتی دست خود…

ادامه مطلب

کسب ربته دوم در رتبه بندی جهانی 4ICU

در جديدترين رتبه بندي وب سايت دانشگاههاي جهان 4ICU دانشگاه علوم پزشکي مشهد در رده دوم کشوري در ميان دانشگاههاي علوم پزشکي کشور قرار گرفت.به گزارش وب دا ، در اين رتبه بندي که نتايج آن در 20 ژانويه 2014 اعلام شده است دانشگاه علوم…

ادامه مطلب
 
English_Category

English_Category

drhashemi

 

دكترمریم هاشمی(PharmD, PhD)

عضو هيئت علمي پژوهشی، دانشکده داروسازی

hashemim[at]mums.ac.ir

 

hashemi_me[at]yahoo.com

 


آدرس: مشهد-میدان فردوسی-میدان بوعلی-پژوهشکده بوعلی-مرکز تحقیقات نانو فناوری
تلفن: 7112470-0511 نمابر: 7112470-0511

 

 
 
 

سوابق تحصیلی

مراتب علمی

دکترای حرفه ای داروسازی، دانشگاه علوم پزشکی مشهد، 77-1371

 عضو هیئت علمی مرکز تحقیقات نانو فناوری – پژوهشکده بوعلی – دانشکده داروسازی مشهد (اردیبهشت  ماه 1391 تا کنون)

دکترای تخصصی (.Ph.D) بیوتکنولوژی دارویی، دانشگاه علوم پزشکی مشهد، 89- 1383

 

دوره تکمیلی Ph.D.، دانشگاه LMU، مونیخ، آلمان، 2009

 

سوابقاجرایی

سوابقتدریس

کارشناس  آزمایشگاه ایمونوبیوشیمی پژوهشکده بوعلی1381-1378

تدریس واحد عملی ایمونولوژی دانشجویان کارشناسی ارشد و دکتری ایمونولوژی1380-1378

سردبیر اجرائی مجله Nanomedicine Journal

تدریس واحد عملی ایمونولوژی دانشجویان کارشناسی علوم آزمایشگاهی1381-1380

 

تدریس واحد بیوتکنولوژی و بیولوژی  مولکولی پیشرفته دانشجویان کارشناسی ارشد پیام نور 1387-1386

   
   

 

 

گرایشهایپژوهشی

سنتز حامل های ژنی غیر ویروسی مورد استفاده در ژن درمانی siRNA delivery  بر پایه پلی مر و پپتید،

فرمولاسیون پروتئین های نوترکیب و عصاره های گیاهی به صورت نانو پارتیکل

 بررسی سمیت نانو ذرات

 
 

 

 

 

Dr. Hashemi

 

Dr Maryam Hashemi

 

 

 

Assistant Professor of Pharmaceutical Biotechnology

 

       

 

 

Address: : Nanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Tel:05137112470

Fax:05137112470

 

این آدرس ایمیل توسط spambots حفاظت می شود. برای دیدن شما نیاز به جاوا اسکریپت دارید

این آدرس ایمیل توسط spambots حفاظت می شود. برای دیدن شما نیاز به جاوا اسکریپت دارید

Updated at: 6/28/2016                          

                                                       und Educational Background 

Pharm.D Thesis:  (1999)

Formulation and Standardization of Topical Preparations (gel, cream, ointment) from Aloes (Dried latex of Aloe).

Supervisor: Dr Noaman Khalili

Mashad University of Medical Sciences, School of Pharmacy

 

PhD Thesis: (2005-2010)

 

Preparation and evaluation of transfect ion efficiency of nanoparticles of polyethyleneimine (PEI) coated with peptide containing Histidine-Lysine rich sequence as non-viral vectors used in gene therapy.

 Supervisor: Dr Mohammad ramezani

Mashad University of Medical Sciences, Bu-Ali Research Institute, Biotechnology Center

 

The project in six month research study: (2009)

 

The effect of targeting of PAMAM dendrimer with GE-11 and B6 peptides

on gene delivery

Supervisor: Dr Manfred Ogris

Pharmaceutical Biology-Biotechnology, Department of Pharmacy, Munich,Ludwig-Maximilians-University of Munich, Germany 

Research Interests

Development of polymer based nanoparticles (non-viral vectors) for plasmid

DNA and siRNA transfer

Formulation of drug, allergen and active natural products based nanoparticles and nanfibers.

Stem cell encapsulation, Stem cell therapy

Publications

  1. Hafezi Ghahestani Z, Alebooye Langroodi F, Mokhtarzadeh A, Ramezani M, Hashemi M*. Evaluation of anti-cancer activity of PLGA nanoparticles containing crocetin. Artif Cells Nanomed Biotechnol. 2016; 21:1-6 (IF: 2.024).
  2. Mokhtarzadeh A, Alibakhshi A, Yaghoobi H, Hashemi M, Hejazi M, Ramezani M. Recent advances on biocompatible and biodegradable nanoparticles as gene carriers. Expert Opin Biol Ther. 2016; 16(6):771-85 (IF:3.43).
  3. Faezeh Moghadam Ariaee, Maryam Hashemi, Sara Amel Farzad, Khalil Abnous and Mohammad Ramezani. Alkyl cross-linked low molecular weight polypropyleneimine dendrimers as efficient gene delivery vectors. Iranian Journal of Basic Medical Sciences (IF: 1.228). In Press.
  4. Nima Hamzian,Maryam Hashemi,Mahdi Ghorbani,Mohammad Ramezani, Mohammad Hossein Bahreyni. osia. Preparation, optimization and toxicity evaluation of (SPION-PLGA) ±PEG nanoparticles loaded with Gemcitabine as a multifunctional nanoparticle for therapeutic and diagnostic applications. Iranian Journal of Pharmaceutical Research (IF: 1.065). In Press.
  5. Maryam Hashemi, Seyed Meghdad Tabatabai, Hamideh Parhiz; Soroush Milanizadeh; Sara Amel Farzad; Khalil Abnous; Mohammad Ramezani. Gene Delivery   Efficiency and Cytotoxicity of Heterocyclic Amine-modified PAMAM and PPI Dendrimers.  Mater Sci Eng C Mater Biol Appl. 2016; 61:791-800 (IF: 3.42)
  6. Fatemeh Alebooye Langroodi, Zohreh Hafezi Ghahestani, Mona Alibolandi, Mahboubeh Ebrahimian, Maryam Hashemi*. Evaluation of the effect of crocetin on antitumor activity of doxorubicinencapsulated in PLGA nanoparticles. Nanomed. J., 2016; 3(1): 23-34,
  7. Ahad Mokhtarzadeh,  Hamideh Parhiz,  Maryam Hashemi,  Khalil Abnous,  Mohammad  Ramezani, P53-Derived peptides conjugation to PEI: an approach to producing versatile and highly efficient targeted gene delivery carriers into cancer cells. Expert Opin Drug Deliv. 2016; 8:1-15 (IF: 5.434).
  8. Hashemi M. and Kalalinia F. Application of encapsulation technology in stem cell delivery.  Life Sciences. 2015; 143: 139–146 (IF: 2.685).
  9. Hashemi M, Ayatollahi S, Parhiz H, Mokhtarzadeh A, Javidi S, Ramezani M. PEGylation of Polypropylenimine Dendrimer with Alkylcarboxylate Chain Linkage to Improve DNA Delivery and Cytotoxicity. Appl Biochem Biotechnol. 2015 Sep; 177(1):1-17 (IF: 1.606).
  10. Mohammadi M, Salmasi Z, Hashemi M, Mosaffa F, Abnous K, Ramezani M. Single-walled carbon nanotubes functionalized with aptamer and piperazine-polyethylenimine derivative for targeted siRNA delivery into breast cancer cells. Int J Pharm. 2015 May 15; 485(1-2):50-60 (IF: 3.99).
  11. Salmasi Z, Shier WT, Hashemi M, Mahdipour E, Parhiz H, Abnous K, Ramezani M. Heterocyclic amine-modified polyethylenimine as gene carriers for transfection of mammalian cells. Eur J Pharm Biopharm. 2015; 96:76-88 (IF: 3.97). 
  12. Ayatollahi S, Hashemi M, Kazemi Oskuee R, Salmasi Z, Mokhtarzadeh A, Alibolandi M, Abnous K, Ramezani M.Synthesis of efficient gene delivery systems by grafting pegylated alkylcarboxylate chains to PAMAM dendrimers: Evaluation of transfection efficiency and cytotoxicity in cancerous and mesenchymal stem cells. J Biomater Appl. 2015; 30(5):632-48 (IF: 1.988).
  13. Mokhtarzadeh A, Parhiz H, Hashemi M, Ayatollahi S, Abnous K, Ramezani M.Targeted Gene Delivery to MCF-7 Cells Using Peptide-Conjugated Polyethylenimine. AAPS PharmSciTech. 2015; 16(5):1025-32. (IF: (IF:1.954).
  14. Hashemi M, Parhiz H, Mokhtarzadeh A, Tabatabai SM, Farzad SA, Shirvan HR, Ramezani M.Preparation of Effective and Safe Gene Carriers by Grafting Alkyl Chains to Generation 5 Polypropyleneimine. AAPS PharmSciTech. 2015; 16(5):1002-12 (IF: 1.954).
  15. Salari F, Varasteh AR, Vahedi F, Hashemi M, Sankain M. Down-regulation of Th2 immune responses by sublingual administration of poly (lactic-co-glycolic) acid (PLGA)-encapsulated allergen in BALB/c mice. Int Immunopharmacol. 2015; 29(2):672-8 (IF: 2.55).
  16. Parhiz H, Hashemi M, Ramezani M. Non-biological gene carriers designed for overcoming the major extra- andintracellular hurdles in gene delivery, an updated review, Nanomed J, 2015; 2(1): 1-20
  17. Maryam Hashemi, Hamideh Sahraie Fard, Sara Amel Farzad, Hamideh Parhiz, Mohammad Ramezani,  Gene Transfer Enhancement by alkylcarboxylation of Poly(propylenimine),  Nanomed. J., 2013; 1(1): 55-62.
  18. Mazdak Ganjalikhani hakemi,  Maryam Hashemi*, SiRNA Delivery Improvement by Co-formulation of Different Modified Polymers in Erythroleukemic Cell Line K562, Iran J Basic Med Sci, 2013, 16: 973-978. (IF: 0.604)
  19. Parhiz H, Hashemi M, Hatefi A, Shier WT, Farzad SA, Ramezani M. Molecular weight-dependent genetic information transfer with disulfide-linked polyethylenimine-based nonviral vectors, J Biomater Appl. 2013 Jul; 28(1):112-24.(IF:2.64)
  20. Parhiz H, Hashemi M, Hatefi A, Shier WT, Amel Farzad S, Ramezani M. Arginine-rich hydrophobic polyethylenimine: Potent agent with simple components for nucleic acid delivery. Int J Biol Macromol. 2013 May 13; 60C:18-27(IF:2.679).
  21. Parhiz H, Memari F, Amel Farzad S, Hashemi M, Rezvani Amin Z, Behnam B and Ramezani M. Alkylcarboxylate Polyethylenimine-grafted Chitosans as Efficient Gene Vectors with Improved Gene delivery Activity. Current Nanoscience, 2013; 9(6): 717-722 (IF:1.64).
  22. Hashemi M., Parhiz BH., Hatefi A., Ramezani M., Modified polyethylenimine with histidine-lysine short peptides as gene carrier, Cancer Gene Ther. 2011 Jan; 18(1):12-9 (IF: 2.945).
  23. Varasteh A.R.,  Hashemi M, Baranzadeh N., Jaafari M.R., Optimization of Anti-Rh D Immunoglobulin Stability in the Lyophilization Processes, Iranian Journal of Basic Medical Sciences, 2008; 11 (1): 55-61 (IF: 0.243).
  24. Hashemi M, Jaafari M.R , Baranzadeh N., Varasteh A.R.,  The assay of effective parameters on Anti-RhD concentration by ultrafiltation system. Iran J Basic Med Sci, 2007; 10(1), 66-74.
  25. Sankian M., Hashemi M., Varasteh A.R., Anti-D quantification by an enzyme-linked antiglobulin test: A comparison study of two methods, Iran J Basic Med Sci, 2004; 7(2): 18-22.
  26. Varasteh A.R., Hashemi M., Jaffari M., Moghadassi Risseh M., Formulation of Anti-Rh (D) immunoglobulin preparation, Iran J Basic Med Sic, 2004; 7(3):11-16.
  27. Varasteh A.R., Hashemi M., Saberpoor F., Study of the effect of plasma lipoprotein on Anti-Rh D purification by ion exchange chromatography, Journal of Birjand University of Medical Sciences, 2003; 10(3):5-9.
  28. Hashemi M., Varasteh A.R., Fazly Bazaz B.S., The role of ion exchange chromatography in purification and amount of aggregation of intravenouse immunoglobulin preparation, Journal of Birjand University of Medical Sciences, 2002;9(1):1-4.
  29. Varasteh A.R., Hashemi M., Ghazavi A., Fazly Bazaz B.S., Large scale
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

     production of Anti-Rh Immunoglobulin by ion exchange chromatography, Iran J Basic Med Sci, 2001;

    4(3):16-21.

Presentations

  1. Farhad Salari, Abdol-Reza Varasteh, Fatemeh Vahedi, Maryam Hashemi, and Mojtaba Sankain. 3rd International Congress on Nanoscience & Nanotechnology (ICNT2015)” 2-3 July 2015, Istanbul, Turkey.
  2. M. Ramezani, M. Hashemi, B.H. Parhiz, A. Hatefi. Modified Polyethylenimine with Histidine-lysine Short Peptides as Gene Carrier. July 4-9,2010. Zurich, Switzerland

 

  1. Hashemi M., Varasteh A.R., Bahrami A., Fazly Bazaz B.S., Stability of AntiD Immunoglobulin prepared by ion exchangechromatography, 11 international congress of immunology and allergy, Sweden, 2001.

 

  1. Hashemi M*, Afkhami F, Ramezani M. Encapsulated stem cells for therapeutic application. International congress on stem cells and regenerative medicine. Mashhad. Iran. May 20-22. 2015.
  2. Maryam Hashemi*. Soheila Javidi, Hamideh Parhiz, Mohammad Ramezani. Effect of PEGylation using an alkyl chain as linker on gene delivery efficiency of  polypropyleneimine denderimer. 4th International symposium on Molecular technology. October 14-16. 2014. Tehran. Iran.
  3. M. Hashemi*, M. Ramezani, Preparation and evaluation of transfection efficiency of nanoparticles of polyethyleneimine(PEI) coated with peptide containing histidine-lysine rich sequence  as non viral vectors used in gene therapy, 8th Nanothechnology Iranian students conference, Mashhad, 1-2Dec, 2010.
 

 

  1. Varasteh A.R., Hashemi M., Fazly Bazaz B.S., Methods of Quantification control on therapeutic immunoglobulins, 1st Seminar of Methodology in Pharmaceutical Sciences, Mashad, Iran, 2002.s                                                 
  2. Hashemi M*, Varasteh A.R., Saberpoor F., Study of the effect of plasma lipoprotein on Anti-Rh D purification by ion exchange chromatography, 6 Congress of Biochemistry, Tehran, Iran, 2001.           
  3. Hashemi M*, Khalili N., Formulation and standardization of topical preparations (gel, cream, ointment) from Aloes ((dried latex of Aloe), 7th  Iranian Seminar of Pharmaceutical Sciences, Mashad, Iran, 2000.
 
 

Administrative Responsibilities

Managing Editor of Nanomedicine Journal, Publisher: Mashhad University of Medical Sciences

Dr. Tafaqodi

 

 

Mohsen Tafaghodi (Pharm.D., Ph.D.)

 

Professor in Pharmaceutics and Nanotechnology

 

 

Address:

School of Pharmacy,

Nanotechnology Research Center,

Mashhad University of Medical Sciences,

Mashhad-Iran

Tel: ++98-51-38823255-66 (Office)

Fax: ++98-51-38823251

tafaghodim[at]mums.ac.ir

Updated at:  June 2016                         

                                                       und Educational Background 

Pharm.D.: School of Pharmacy, Mashhad University of Medical Sciences (1991-1997).

Ph.D. (Pharmaceutics): School of Pharmacy, Mashhad University of Medical Sciences (1997-2003). Ph.D. thesis title: Nasal immunization using biodegradable microspheres and liposomes: Tetanus toxoid as a model

 

Research fellowships:

1-      School of Pharmacy, University of Alberta, Canada (cancer vaccination using nano- and microparticulate drug delivery systems). 2001.

2-      Leiden/Amsterdam center for Drug Research, University of Leiden, Netherland (preparation and characterization and in vivo study of TMC:HBsAg and chitosan:HBsAg nanoparticles as a nasal delivery /adjuvant system). 2011.

 

 

 

Research Interests

Mucosal and systemic vaccine and drug delivery by nanoparticulate and microparticulate delivery systems (nanospheres, microspheres and liposomes)

 

 

 

 

Publications

Books

1. Tafaghodi, M., Amiri, R., Hosseinzadeh, H., 1998. Adverse Effects of Herbal Drugs. Volume 1, MUMS Press, Mashhad. (Translation), 4th print 2007.

2. Tafaghodi, M., Hosseinzadeh, H., 2002. Adverse Effects of Herbal Drugs. Volume 2, MUMS Press, Mashhad. (Translation), 3rd print, 2007.

3. Hosseinzadeh, H., Tafaghodi, M., 2006. Adverse Effects of Herbal Drugs. Volume 3, MUMS Press, Mashhad. (Translation).

4. Afrasiabi, H., Tafaghodi, M., Sajadi, S.A., Sadeghi, F., 2006. Pharmacetics, the science of dosage form design. Volume 1, MUMS Press, Mashhad. (Translation, 2nd print, 2009).

5. Afrasiabi, H., Tafaghodi, M., Sajadi, S.A., Sadeghi, F., Fazly, B.S., 2007. Pharmacetics, the science of dosage form design. Volume 2. (Translation), 2nd print, 2010.

6. Imenshahidi, M., Moallem, S.A., Tafaghodi, M., Rezaei, Ramin, Firouzi, Zohreh, 2011. Nonprescription Drug Therapy. MUMS press, Mashhad. (Translation)

7. Afrasiabi, H., Tafaghodi, M., Sajadi, S.A., Sadeghi, F., Fazly, B.S., 2013. Aulton’s Pharmacetics, the design and manufacture of medicines. Volume 1, MUMS Press, Mashhad. (Translation, 2015).

8. Afrasiabi, H., Tafaghodi, M., Sajadi, S.A., Sadeghi, F., Fazly, B.S., 2013. Aulton’s Pharmacetics, the design and manufacture of medicines. Volume 2, MUMS Press, Mashhad. (Translation, 2015).

 

Papers

1- Diwan, M., Tafaghodi, M., Samuel, J., 2002. Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres. Journal of Controlled Release, 85, 247-262

2- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R., 2002. Drug delivery from nasal route. Razi,, 155, 32-42.

3- Tafaghodi, M., Hasanzadeh, M., Rahimizadeh, M., 2003. Isolation and identification of Hyoscyamus insanus alkaloids. Iranian journal of Medicinal Plants, 2(7), 29-36.

4- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R.., 2004. Utilization of particulate and immuno-modulating adjuvants for enhancement of immune responses against tumors antigenic markers. Iranian Journal of Basic Medical Sciences, 6(4), 336-345.

5- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R., Zakavi, S.R., Momen-nejad, M., 2004. Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy. International Journal of Pharmaceutics, 280, 125-135.

6- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R.., 2004. Mucosal immunization. Razi, 175, 17-24.

7- Tafaghodi, M., Jaafari, M.R.., Sajadi Tabasi, S.A., 2004. Adjuvants. Razi, 174, 34-45.

8- Sajadi Tabasi, S.A., Tafaghodi, M., Jaafari, M.R., 2004. Dextran microspheres encapsulated with tetanus toxoid as a delivery system for nasal immunization: in vitro and in vivo characterization.  Iranian Journal of Basic Medical Sciences, 7(2), 88-98.

9- Jaafari, M.R., Tafaghodi, M., Sajadi Tabasi, S.A., 2005. Evaluation of the clearance characteristics of liposomes in the human nose by gamma-scintigraphy. Iranian Journal of Pharmaceutical Research, 4(1), 3-11.

10- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R., 2006. Formulation and characterization and release studies of alginate microsphere encapsulated with tetanus toxoid. Journal of Biomaterials Science. Polymer Edition., 17(8), 909-924.

11- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R., 2006. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN. International Journal of Pharmaceutics, 319, 37-43.

12- Tafaghodi, M., Jaafari, M.R., Sajadi Tabasi, S.A., 2006. Nasal immunization studies by liposomes encapsulated with tetanus toxoid and CpG-ODN. European Journal of Pharmaceutics and Biopharmaceutics, 64, 138-145.

13- Tafaghodi, M., Jaafari, M.R., Nikouzadeh, A. 2007. Evaluation of systemic and mucosal immune responses following the nasal immunization by various sizes of liposomes encapsulated with tetanus toxoid. Iranian Journal of Basic Medical Sciences, 9, 4(32), 307-315.

14- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R., 2007. Nasal immunization study by PLGA nanospheres encapsulated with tetanus toxoid and CpG-ODN. Iranian Journal of Pharmaceutical Research, 6(3), 151-158.

15- Ghiasi, Z., Sajadi Tabasi, S.A., Tafaghodi, M., 2007. Preparation and In Vitro  Characterization of Alginate Microspheres Encapsulated with Autoclaved Leishmania major (ALM) and CpG –ODN. Iranian Journal of Basic Medical Sciences, 10(2), 90-98.

16- Tafaghodi, M., Sajadi Tabasi, S.A., Payan, M., 2007. Alginate microspheres as delivery system and adjuvant for autoclaved Leishmania major (ALM) and Quillaja saponin (QS) - Preparation and characterization. Iranian Journal of Pharmaceutical Sciences, 3(2), 61-68.

17- Nazemian, F., Mohammad-Poor, A-H, Naghibi, M, Hasanzadeh-Khayat, M., Tafaghodi, M., Charkazi, S, Abrisham, S., 2007. The effect of pentoxiphylline on hemoglobin levels in patients with erythropoietin resistant anemia in hemodialysis patients. Nephrology Dialysis Transplantation, 22(Supplement 6), 355-355.

18- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R., 2008. Nasal immunization studies by cationic, fusogenic and cationic-fusogenic liposomes encapsulated with tetanus toxoid. Current Drug Delivery, 5, 108-113.

19- Tafaghodi, M., Sajadi Tabasi, S.A., Kharazizadeh, M., 2008. Preparation and characterization of PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and Quillaja saponin. Saudi Pharmaceutical Journal, 16(1), 43-49.

20- Sajadi Tabasi, S.A., Tafaghodi, M., Jaafari, M.R., 2008. Induction of high antitoxin titers against tetanus toxoid in rabbits by intranasal immunization with dextran  microspheres. International Journal of Pharmaceutics, 360, 12-17.

21- Tafaghodi, M., Hadizadeh, F., Farahmand, F., 2008. Comparison of spectrophotometry and spectroflourimetry methods in determination of encapsulation efficiencies of TT in microspheres and liposomes, Pharmaceutical Sciences, summer, 53-59.

22- Tafaghodi, M., Sajadi Tabasi, S.A., Amiri, N., 2008. PLGA nanospheres loaded with Autoclaved Leishmania Major (ALM) and CpG-ODN: Preparation and in vitro characterization. Iranian Journal of basic medical Sciences, 11(2), 112-119.

23- Deldar, K., Nazemi, E., Balali Mood, M., Emami, S.A., Mohammadpour, A.H., Tafaghodi, M., Afshari, R., 2008. Effect of Coriandrum sativum L. extract on lead excretion in 3-7 year old children, Journal of Birjand University of Medical Sciences, 15, 11-19.   

24- Amin, M.R., Jaafari, M.R., Tafaghodi, M., 2009. Nasal immunization studies in rabbits by anionic and chitosan coated liposomes encapsulated with tetanus toxoid as a model antigen. Colloids and Surfaces B. Biointerfaces, 74, 225-229.

25- Khadivzadeh, T., Samadi, S., Emami, A., Tafaghodi, M., Sanjar Moosavi, N., Behnam, H.R., 2010. The Effect of Hypericum Perforatum on the Wound Healing and Scar of Cesarean. Journal of Alternative and Complementary Medicine, 16(1), 113-117.

26- Tafaghodi, M., Rastegar, S., 2010. Preparation and in vivo study of dry powder microspheres for nasal immunization. Journal of Drug Targeting, 18(3), 235-242.

27- Emami, S.A., Fakhrjafary, M., Tafaghodi, M., Hassanzadeh, M.K., 2010. Chemical Composition and Antioxidant Activities of the Essential Oils of Different Parts of Cupressus arizonica Greene. Journal of Essential Oil Research, 22, 193-199.

28- Tafaghodi, M., Jaafari, M.R., Eskandari, M., Khamesipour, A., 2010. Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental Autoclaved Leishmania major (ALM) and Quillaja saponins. Tropical Biomedicine, 27, 639-650.

29- Alipour, S., Montaseri, H., Tafaghodi, M., 2010. Preparation and characterization of paclitaxel loaded alginate microparticles for pulmonary delivery. Colloids and Surfaces B. Biointerfaces, 81, 521-529.

30- Mohaghegh, M., Tafaghodi, M., 2011. Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and Quillaja saponins after nasal immunization in rabbit. Pharmaceutical Development and Technology, 16, 36-43.

31- Tafaghodi, M., Khamesipour, A., Jaafari, M.R., 2011. Immunization against leishmaniasis by PLGA nanospheres encapsulated with Autoclaved Leishmania major (ALM) and CpG-ODN. Parasitology Research, 108, 1265-1273.

32- Tafaghodi, M., Eskandari, M., Khamesipour, A., Jaafari, M.R., 2011. Alginate microspheres encapsulated with Autoclaved Leishmania major (ALM) and CpG-ODN induced partial protection and enhanced immune response against murine model of leishmaniasis. Experimental Parasitology, 129, 107-114.

 33- Maleki, M., Karimi, G., Tafaghodi, M., Raftari, S., Nahidi, Y., 2012. Comparison of Intralesional 2% zinc sulfate and Glucantime injection in treatment of acute cutaneous Leishmaniasis. Indian Journal of Dermatology, 57, 118-122.

34- Tafaghodi, M., Eskandari, M., 2012. The mucosal adjuvant potential of cross-linked dextran microspheres (CDM) as dry powder. Iranian Journal of Basic Medical Sciences, 15, 873-879.

35- Moghadam Aryaee, F., Tafaghodi, M., 2012. Mucosal adjuvant potential of Quillaja saponins and cross-linked dextran microspheres, co-administered with liposomes encapsulated with tetanus toxoid. Iranian Journal of Pharmaceutical Research, 11(3), 723-732.

36- Khodaverdi, E., Tafaghodi, M., Ganji, F., Abnoos, K., Naghizadeh, H., 2012. In vitro insulin release from thermosensitive chitosan hydrogel.  AAPS PharmSciTech, 13, 460-466.

37- Tafaghodi, M., Saluja, V., Kersten, G.F.A., Kraan, H., Slütter, B., Amorij, J.-P., Jiskoot W., 2012. Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: impact of formulation on physicochemical and immunological characteristics. Vaccine, 30, 5341-5348.

38- Moghimipour, E., Tafaghodi, M., Balouchi, A., Handali, S., 2013. Formulation and in vitro Evaluation of Topical Liposomal Gel of Triamcinolone Acetonide. Research Journal of Pharmaceutical, Biological and Chemical Sciences (RJPBCS), 4, 101-107.

39- Hosseinzadeh, H., Tafaghodi, M., Moosavi, M.J., Taghiabadi, E., 2013. Effect of Aqueous and Ethanolic Extracts of Nigella sativa Seeds on Milk Production in Rats. JAMS Journal of Acupuncture and Meridian Studies, 6, 18-23. 

40- Zarifpour, M., Hadizadeh, F., Iman, M., Tafaghodi, M., 2013. Preparation and characterization of trimethylchitosan (TMC) nanospheres encapsulated with tetanus toxoid. Pharmaceutical Sciences, 1(2), 13-18.

41- Dehghan, S., Tavassoti Kheiri, M., Tabatabaiean, M., Darzi, S., Tafaghodi, M., 2013. Dry-powder form of chitosan nanospheres containing infulenza virus and adjuvants for nasal immunization. Archives of Pharmacal Research, 36:981-992.

42- Ganji, F., Khodaverdi, E., Tafaghodi, M., Sadoogh, M., 2013. Effects of Formulation Properties on Sol-Gel Behavior of Chitosan/glycerolphosphate Hydrogel. Iranian Polymer Journal, 22:785-790.

43- Khodaverdi, E., Tafaghodi, M., Beizaei, S., Abnous, Kh., Alibolandi, M., and Hadizadeh, F., 2013. Preparation and Characterization of PLGA-PEG-PLGA nanospheres prepared with a new thermogelling method for Insulin Delivery. Journal of Chemical and Pharmaceutical Research, 5, 311-319.

44- Khameneh Bagheri, B., Momen-nejad, M., Tafaghodi, M., 2014. In vivo evaluation of mucoadhesive properties of nanoliposomal formulations upon coating with trimethylchitosan polymer. Nanomedicine Journal, 1(3), 147-154.

45- Mohammadpour, A.H., Nazemian, F., Hasanzadeh, M., Tafaghodi, M., Salari, P., Charkazi, S., Naghibi, M., Shamsara, J., 2014. Evaluation of the effect of pentoxifylline on erythropoietin-resistant anemia in hemodialysis patients. Saudi Journal of Kidney Diseases and Transplantation, 25, 73-78.

46- Razavi Rohani, S.S., Abnous, K., Tafaghodi, M., 2014. Preparation and characterization of spray-dried powders intended for pulmonary delivery of Insulin with regard to the selection of excipients. International Journal of Pharmaceutics, 465, 464-478.

47- Tafaghodi, M., Kersten, G.F.A, Jiskoot, W., 2014. Nano-adjuvanted polio vaccine: Preparation and characterization of chitosan and trimethyl chitosan (TMC) nanoparticles loaded with inactivated polio virus and coated with sodium alginate. Nanomedicine Journal, 1(4), 220-228.

48- Hosseinzadeh, H., Tafaghodi, M., Abedzadeh, S., Taghiabadi, E., 2014. Effect of Aqueous and Ethanolic Extracts of Pimpinella anisum L. Seeds on Milk Production in Rats. Journal of Acupuncture and Meridian Studies, 7(4), 211-216.

49- Ghoochi Atashbeyk, D., Khameneh Bagheri, B., Tafaghodi, M., Fazly Bazzaz, B.S., 2014. Eradication of methicillin-resistant Staphylococcus aureus infection by nanoliposomes loaded with gentamicin and oleic acid. Pharmaceutical Biology, 52 (11), 1423-1428.

50- Mohajer, M., Khameneh, B., Tafaghodi, M., 2014. Preparation and characterization of PLGA nanospheres loaded with inactivated influenza virus, CpG-ODN and Quillaja saponin. 17, 722-726.

51- Khodaverdi, E., Heidari, Z., Sajadi Tabassi, S.A., Tafaghodi, M., Alibolandi, M., Mirzazadeh Tekie, F.S., Khameneh, B., Hadizadeh, F., 2014. Injectable supramolecular hydrogel from insulin-loaded triblock PCL-PEG-PCL copolymer and γ-cyclodextrin with sustained-release property. AAPS PharmSciTech, 16(1), 141-149.

52- Dehghan, S., Tafaghodi, M., Bolourieh, T., Mazaheri, V., Torabi, A., Abnous, KH., Tavassoti Kheiri, M., 2014. Nasal immunaization against influenza by chitosan nanospheres encapsulated with Influenza whole virus and adjuvants in dry-powder form. International Journal of Pharmaceutics, 475, 1-8.

53- Kazemi-Beydokhti, A., Zinali heris, S., Tafaghodi, M., Jaafari, M.R., Hatamipoor, M., 2014. Microwave functionalized single-walled carbon nanotube as nanocarrier for the delivery of anticancer drug cisplatin: in vitro and in vivo evaluation. Journal of Drug Delivery Science and Technology, 24(6), 572-578.

54- Moayedian, T., Mosaffa, F., Khameneh-Bagheri, B., Tafaghodi, M., 2015. Combined effects of PEGylation and particle size on uptake of PLGA particles by macrophage cells. Nanomedicine Journal, 2(4), 299-304.

55- Mehravaran, A., Jaafari, M.R., Jalali, S.A., Khamesipour, A., Tafaghodi, M., Hojatizade, M., Badiee, A., 2015. The role of surface charge of ISCOMATRIX nanoparticles on the type of immune response generated against Leishmaniasis in BALB/c mice. Nanomedicine Journal, 2(4), 249-260.

56- Montaseri, H., Alipour, S., Tafaghodi, M., 2015. Inhalable, large porous PLGA microparticles loaded with pcalitaxel: Preparation, in vitro and in vivo characterization. Journal of Microencapsulation, 32(7), 661-668.

57- Rady Raz, N., Akbarzadeh-T, M.R., Tafaghodi, M., 2015. Bio-inspired Nanonetworks for Targeted Cancer Drug Delivery. IEEE Transaction of Nanobiosience, 14(8), 894-906.

58- Mehravaran, A., Jaafari, M.R., Jalali, S.A., Khamesipour, A., Tafaghodi, M., Hojatizade, M., Badiee, A., 2015. The role of surface charge of ISCOMATRIX nanoparticles on the type of immune response generated against Leishmaniasis in BALB/c mice. Nanomedicine Journal 2 (4), 249-260.

59- Mehravaran, A., Jaafari, M.R., Jalali, S.A., Khamesipour, A., Tafaghodi, M., Hojatizade, M., Abbasi, A., Badiee, A., 2015. Cationic Immune Stimulating Complexes Containing Soluble Leishmania Antigens: Preparation, Characterization and in Vivo Immune Response Evaluation. Iranian Journal of Immunology 12 (4), 274.

60- Radvar, M., Moeintaghavi, A., Tafaghodi, M., Ghanbari, H., Fatemi, H., Mokhtari, M.R., Najafi, F., Hoseinipour, Z., Dastmalchi, P., Farazi, F., 2016. Clinical efficacy of herbal mouth wash composed of Salix alba, Malva sylvestris and Althaea officinalis in chronic periodontitis patients. Journal of Herbal Medicine, 6, 24-27.

61- Shiehzadeh, F., Tafaghodi, M., 2016. Dry powder form of polymeric nanoparticles for pulmonary drug delivery. Current Pharmaceutical Design, 22(17), 2549-2560.

62- Amirnasr, M., Fallah-tafti, T., Sankian, M., Rezaei, A., Tafaghodi, M., 2016. Immunization against HTLV-1 with CHT and TMC nanoparticles loaded with recombinant env23 and env13 antigens of envelope protein gp46. Microbial Pathogenesis, 97, 38-44.

63- Alipour, S., Montaseri, H., Nekouian, A.A., Khalili Azad, A., Mohamadpour, A.H., Tafaghodi, M., 2016. Non-invasive endotracheal delivery of paclitaxel loaded alginate microparticles: pharmacokinetic study. Journal of Chemotherapy (In Press).

64- Tafaghodi, M., Jaafari, M-R. Eskandari, M., Khamesipour, A., 2016. Immunization against cutaneous leishmaniasis by Alginate microspheres loaded with Autoclaved Leishmania major (ALM) and Quillaja saponins. Iranian Journal of Pharmaceutical Research (In Press).

65- Hadizadeh, F., Khodaverdi, E., Javan, M., Tafaghodi, M., Sajadi Tabassi, S.A., Chamani, J., Khameneh, B., Mirzazadeh Tekie, F.S., 2016. Sustained Drug Delivery System for Insulin using Supramolecular Hydrogels Composed of Tri-block Copolymers. Submitted to IJPR.

66- Amini, Y., Moradi, B., Tafaghodi, M., Meshkat, Z., Ghazvini, K., Fasihi-Ramandi, M., 2016. TB trifusion antigen adsorbed on calcium phosphate nanoparticles stimulated strong cellular immunity in mice. Submitted to experimental nanoscience.

67- Karimi, S.M., Sankian, M., Khademi, F., Tafaghodi, M., 2016. Chitosan (CHT) and trimethylchitosan (TMC) nanoparticles as adjuvant/delivery system for parenteral and nasal immunization against Mycobacterium tuberculosis (MTb) ESAT-6 antigen. Submitted to Microbiology and Immunology.

68- Pirouzmand, H., Khameneh, B., Tafaghodi, M., 2016. Evaluation of immunoadjuvant potential of dry powder form of cross-linked dextran microspheres (CDM) mixed with chitosan ‎nanospheres encapsulated with tetanus toxoid, after nasal ‎immunization in rabbits. Submitted to Pharmaceutical Biology.

69- Amini, Y., Tafaghodi, M., Amel Jamehdar, S., Meshkat, Z., Moradi, B., Sankian, M., 2016. Heterologous expression, purification and characterization of the HspX, Ppe44 and EsxV proteins of Mycobacterium tuberculosis as a vaccine candidate in prokaryotic system. Submitted to Asian Pacific Journal of Tropical Medicine.

70- Dehghan, S., Kheiri, M.T., … , Tafaghodi, M., 2016. Dry powder vaccine preparation, characterization and immunogenic evaluation of Alginate-based whole inactivated influenza nasal vaccine in rabbits. Submitted to journal of Colloids and Surfaces B.

71- Mosafer, J., Abnous, Kh., Tafaghodi, M., Ramezani, M., 2016. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy. Submitted to Applied surface Science.

 

 

 

 

 

 

 

 

 

 

Presentations

1- Tafaghodi, M. Shokouhi Nejad, H., 1995. Evaluation of different methods of determination of poor soluble substances. Proceeding of the 2nd congress of Iranian pharmacy students, Mashhad, Iran.

2- Moghimipour E., Dehghan G. and Tafaghodi M., 1998. The study of HPMC concentrations on physical properties of coated tablets. Proceeding of the 6th Iranian Congress of Pharmaceutical Sciences, Tehran, Iran.

3- Tafaghodi M., Rahimizadeh M., Hassanzadeh M., 2000. Isolation and characterization of alkaloids of Hyoscyamus insanus. Proceeding of the 7th Iranian Congress of Pharmaceutical Sciences, Mashhad, Iran.

4- Tafaghodi, M., Jaafari, M.R., Sajadi Tabasi, S.A., 2000. Formulation and characterization of liposomes containing tetanus toxoid. Proceeding of the 7th Iranian Congress of Pharmaceutical Sciences, Mashhad, Iran.

5- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R., 2002. Preparation and characterization of alginate microspheres encapsulated with tetanus toxoid for nasal delivery. Proceeding of the 8th Iranian Congress of Pharmaceutical Sciences, Shiraz, Iran.

6- Tafaghodi, M., Diwan, M., Samuel, J., Jaafari, M.R., Sajadi Tabasi, S.A., 2002. Increasing the immune responses by co-delivery of tetanus toxoid and CpG ODN encapsulated in PLGA nanospheres­. Proceeding of the 8th Iranian Congress of Pharmaceutical Sciences, Shiraz, Iran.

7- Tafaghodi, M., Zakavi, S.R., Sajadi Tabasi, S.A., Jaafari, M.R., Momen Nejad, H., 2002. Gamma-Scintigraphy as a novel method to study the distribution and clearance rate of different mucoadhesive nasal delivery systems. Proceeding of the 6th Annual Meeting of Nuclear Medicine, Mashhad, Iran.

8- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R.., 2003. Nasal immunization using alginate microspheres encapsulated with tetanus toxoid (TT). Proceeding of the 1st Congress of New Drug Delivery Systems, Tehran, Iran.

9- Sajadi Tabasi, S.A., Tafaghodi, M., Jaafari, M.R.., 2003. Nasal immunization using cross-linked dextran microspheres encapsulated with tetanus toxoid (TT). Proceeding of the 1st Congress of New Drug Delivery Systems, Tehran, Iran.

10- Tafaghodi, M., Jaafari, M.R.., Sajadi Tabasi, S.A., 2003. Nasal immunization using neutral, cationic, fusogenic and cationic-fusogenic liposomes encapsulated with tetanus toxoid (TT). Proceeding of the 1st Congress of New Drug Delivery Systems, Tehran, Iran.........

11- Tafaghodi, M., Samuel, J., Diwan, M., Sajadi, S.A., Jaafari, M.R., 2003. Utilization of particulate and immunomodulating adjuvants for enhancement of immune response against tumors antigenic markers. Proceeding of the 3rd Congress of National Biotechnology, Mashhad, Iran.

12- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R.., 2006. Nasal immunization studies by alginate and cross-linked dextran microspheres and PLGA nanospheres encapsulated with tetanus toxoid (TT). Proceeding of the 10th Iranian Congress of Pharmaceutical Sciences, Tehran, Iran.

13- Tafaghodi, M., Sajadi Tabasi, S.A., Kharazizadeh, M., 2007. Preparation and characterization of PLGA nonospheres encapsulated with autoclaved Leishmania major (ALM) and saponin adjuvant. Proceeding of the 3rd Congress of New Drug Delivery Systems, Tehran, Iran.

14- Tafaghodi, M., Hadizadeh, H., Farahmand, F., 2007. Determination of encapsulation efficiency of fluorescent tetanus toxoid in microsphere and Liposome drug delivery systems by spectrofluorimetery method. Proceeding of the 3rd Congress of New Drug Delivery Systems, Tehran, Iran.

15- Tafaghodi, M., Jaafari, M.R., Amin, M.R., 2007. Nasal Immunization Studies in Rabbits by Anionic and Chitosan Coated Liposomes Encapsulated with Tetanus Toxoid as a Model Antigen. Proceeding of the 1st Vaccine Congress, Amsterdam, Netherland.

16- Tafaghodi, M., Jaafari, M.R., Sajadi Tabasi, S.A., 2008. Preparation, characterization and immunization studies with PLGA nonospheres encapsulated with autoclaved Leishmania major (ALM) and saponin adjuvant. Proceeding of the 11th Iranian Congress of Pharmaceutical Sciences, Kerman, Iran.

17- Tafaghodi, M., 2009. Nanoparticulate drug delivery systems as vaccine adjuvant and delivery system. Proceeding of the Nanodrugs, nano-biotechnology, nano-biosensors and nano-materials in medical sciences. Mashhad, Iran.

18- Tafaghodi, M., Jaafari, M.R., Sajadi, S.A., Khamesipour, A., Amiri, N., 2009. Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN. ICRC 2009, Zanjan, Iran.

19- Tafaghodi, M., Mohaghegh, M., 2009. Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and Quillaja saponins after nasal immunization in rabbit. ICRC 2009, Zanjan, Iran. 

20- Tafaghodi, M., Jaafari, M.R., Sajadi Tabasi, S.A., 2009. Induction of immune responses against leishmaniasis by alginate microspheres encapsulated with autoclaved Leishmania major (ALM) antigen and CpG-ODN.  Proceeding of the 3rd Modern vaccine adjuvant and delivery systems, Vienna, Austeria.

21- Tafaghodi, M., Jiskoot, W., Saluja, V., 2011. Hepatitis B surface antigen (HBsAg) nanoparticles coated with chitosan and trimethyl chitosan (TMC): impact of formulation on physicochemical and immunological characteristics.

 

22- Tafaghodi, M., 2016. Polymer based nanoparticles as adjuvant/vaccine delivery system for systemic and mucosal immunizations. 13th International Congress of Immunology and allergy of Iran. Tabriz, Iran.

 

 

 

 

 

 

 

 

 

 

Honors & Awards

Honored investigator (student) in medicinal sciences, Ferdowsi Festival, Mashhad, 2001 (Offered by MUMS and FUM).

Honored Pharmacist, Mashhad, 2002 (Offered by Khorasan Association of Pharmacists).

The best presentation in 8th Iranian Seminar of Pharmaceutical Scientists (Ph.D. student), Shiraz, 2002 (Offered by Iranian Association of Pharmaceutical Scientists).

Honored young researcher, 9th Iranian Seminar of Pharmaceutical Sciences, Tabriz, 2004 (Offered by Iranian Association of Pharmaceutical Scientists).

The best book translation (Adverse effects of herbal drugs vol. 1 and 2), Research week festival, Mashhad, 2004 (Offered by MUMS)

Three awards from Iranian Nanotechnology Initiative for supervision of two Pharm.D. thesis.

The best book translation (Pharmaceutics, vol. 1), Research week festival, Mashhad, 2006 (Offered by MUMS)

Honored lecturer, MOALEM week festival, Mashhad, 2007 (Offered by MUMS)

The best book translation (Pharmaceutics, vol. 2), Research week festival, Tehran, 2007 (Offered by University of Tehran)

The best book translation (Pharmaceutics, vol. 2), Research week festival, Mashhad, 2007 (Offered by MUMS)

The best presentation in ICRC 2011, Mashhad, 2011 (Offered by Iranian Controlled Release Society).

The best book translation (Nonprescription Drug Therapy), Research week festival, Mashhad, 2011 (Offered by MUMS)

The best book translation (Pharmaceutics, vol. 1), Research week festival, Mashhad, 2015 (Offered by MUMS).

 

 

 

 

 

Members                                                  hip Membership

Member of “Nanotechnology Research Center”, Mashhad University of Medical Sciences

Member of “Pharmaceutical Research Center”, Mashhad University of Medical Sciences

Member of “Controlled Release Society of Iran”

Editorial member of Asian Pacific Journal of Tropical Medicine (2009-2011)

Editorial member of Nanomedicine Journal

Reviewer of Drug Development and Industrial Pharmacy journal

Reviewer of Journal of Drug Targeting

Reviewer of Journal of Microencapsulation

Reviewer of Journal of the Taiwan Institute of Chemical Engineers

Reviewer of Iranian Journal of Pharmaceutical Research

Reviewer of Iranian Journal of Basic Medical Sciences

Reviewer of DARU journal

Reviewer of Colloids and Surfaces, B journal

 

 

 

Administrative Responsibilities

 

 

 

 

 

 

Other Skills

 

 

 

 

Dr. Badiee

Curriculum Vitae

 

Ali Badiee (Pharm. D., Ph. D.)

 

Assistant Professor in Pharmaceutics,

School of Pharmacy,

Mashhad University of Medical Sciences,

Mashhad-Iran

P.O.Box: 91775-1365

Mobile phone: 09153588537

Phone: 0098-511-8823255(Office)

Fax: 0098-511-8823251

E-mail: Badieea این آدرس ایمیل توسط spambots حفاظت می شود. برای دیدن شما نیاز به جاوا اسکریپت دارید or این آدرس ایمیل توسط spambots حفاظت می شود. برای دیدن شما نیاز به جاوا اسکریپت دارید

Date of birth: September 20th, 1975

Place of birth: Gorgan, Iran

Marital status: Married

 

Education and training:

- Research fellowship: School of Pharmacy, University of Queensland, Australia.

- Ph.D. (Pharmaceutics): School of Pharmacy, Mashhad University of Medical Science (2001-2006).

- Pharm. D: School of Pharmacy, Mashhad University of Medical Science (1993 -1999).

 

Workshops:

- ‘Basic pharmacokinetic-pharmacodynamics in drug development’, Tehran, 2003.

- ‘Internal evaluation of education planning’, Tehran, 2007.

- ‘Curriculum planning’, Mashhad, 2008.

- ‘Introduction to medical digital library resources’, Mashhad, 2008.

- ‘Biosafety practices and vaccine production’, Mashhad, 2009.

- ‘Good Clinical Practice’, Mashhad, 2009.

- ‘Microsoft Outlook’, Mashhad, 2009.

- ‘Microsoft Word’, Mashhad, 2009.

- ‘Microsoft Outlook’, Mashhad, 2009.

- ‘Microsoft Word’, Mashhad, 2009.

- ‘Microsoft Excel’, Mashhad, 2009.

- ‘Whole animal body imaging’, Tehran, 2010.

- ‘Overview of vaccine products and their quality controls’, Tabriz, 2010.

- ‘Scientific articles writing and publishing methods’, Mashhad, 2010.

- ‘Introduction to research and research methods’, Mashhad, 2010.

- ‘Introduction to atomic force microscopy (AFM) and particle size analysis (PSA)’, Zanjan, Iran.

 

 

Research interests:

Targeted drug and/or vaccine nanodelivery systems, Peptide and protein formulation, Liposome based vaccination, Liposomal drug/gene delivery.

 

Thesis:

- Research fellowship project: Targeting to dendritic cells with anti DEC-205 Immunoliposomes: an effective procedure for vaccination or immunotherapy against cancer

- Ph.D. thesis: Formulation, characterization, and evaluation of immune response of liposomes co-encapsulated leishmania antigens and CpG oligodeoxynucleotide adjuvant against leishmaniasis in murine model

- Pharm. D. thesis: Crystal habit modifications of Ibuprofen and their tableting and physico-mechanical characteristics

 

Supervisors:

- Research fellowship project: Prof. Derek Hart, Dr. Masato Kato, Dr. Nigel Davies

- Ph.D. thesis: Dr. Mahmoud Reza Jaafari, Dr. Ali Khamesipour

- Pharm. D. thesis: Dr. Hadi Afrasiabi Garekani

 

Honors & Awards:

1) The best PhD dissertation in 11th Iranian seminar of pharmaceutical scientists, Kerman, Iran, 2008 (Offered by Iranian association of pharmaceutical scientists).

2) Second rank in modern technology, The 13th Razi Research Festival on Medical Sciences, Iran, 2007

 

Publications:

- H. Hejazi, M. Tasbihi, M. R. Jaafari, A. Badiee, N. Pestechian, A. Javadi, A. Khamesipour, 2010. The role of liposomal CpG ODN on the course of L. major infection in BALB/c mice, Iranian J Parasitol, 5(1): 47-54.

 

- A. Badiee, M. R. Jaafari, A. Khamesipour, 2009. The role of liposome size on the type of immune response and protection rate induced against leishmaniasis in BALB/c mice: rgp63 as a model antigen, (submitted in Journal of Nanoparticle Research).

- A. Badiee, M. R. Jaafari, A. Khamesipour, A. Samiei, D. Soroush, M. T. Kheiri, F. Barkhordari, W. R. McMaster, F. Mahboudi, 2009. The role of liposome charge on immune response generated in BALB/c mice immunized with rgp63, Experimental Parasitology,121, 362-369.

 

- A. Badiee, M. R. Jaafari, A. Khamesipour, 2009. Enhancement of immune response and protection in BALB/c mice immunized with liposomal recombinant major surface glycoprotein of Leishmania (rgp63): The role of bilayer composition, Colloids and Surfaces B: Biointerfaces, 74(1):37-44.

 

- A. Badiee, M. R. Jaafari, A. Samiei, D. Soroush, A. Khamesipour, 2008. Co-encapsulation of CpG ODN with rLmSTI1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB/c mice, Clinical and Vaccine Immunology, 15, 668-674.

 

- A. Badiee, N. M. Davies, K. McDonald, K. Radford, H. Michiue, D. N. J. Hart, M. Kato, 2007. Enhanced delivery of immunoliposomes to human dendritic cells by targeting the multilectin receptor DEC-205, Vaccine, 25, 4757–4766.

 

- M. R. Jaafari, A. Badiee, A. Samiei, D. Soroush; M. T. Kheiri, F. Barkhordari, A. Khamesipour, W. R. McMaster, F. Mahboudi, 2007. The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome, Vaccine, 25, 6107–6117.

 

- A. Badiee, M. R. Jaafari, A. Khamesipour, 2007. Leishmania major: Immune   response in BALB/c mice immunized with stress-inducible protein 1 encapsulated in liposomes, Experimental Parasitology,115, 127-134.

 

- Y. Sohrabi, M. R. Jaafari, A. Badiee, S. H. Hejazi, S. E. Eskandari, A. M. Mohammadi, A. Khamesipour, 2007. Evaluation of immune response against autoclaved Leishmania major incorporated into positively charged liposomes in BALB/c mice, Iranian Journal of Dermatology, 10, 37-53.

 

- A. Badiee, M. R. Jaafari, A. Samiei, D. Soroush, A. Khamesipour, 2006. Immune response evaluation against leishmaniasis using liposomes containing rLmSTI1 in murine model, Iranian Journal of Basic Medical Sciences, 8, 215-225.

 

- H. A. Garekani, F. Sadeghi, A. Badiee, S. A. Mostafa, A. R. Rajabi-Siahboomi, 2001. Crystal habit modifications of ibuprofen and their physico-mechanical characteristics, Drug Development and Industrial Pharmacy, 27, 803-809.

 

- H. A. Garekani, F. Sadeghi, A. Badiee, 1999, Investigation of the physico-mechanical properties of modified crystals of ibuprofen, Iranian Journal of Basic Medical Sciences, 2, 8-17.

 

 

Conference presentations:

1) A. Badiee, Y. Sohrabi, M. Ghaemi, Protective effect of non-Ionic surfactants on acidic hydrolysis process of Aspirin. Proceeding of the 3rd congress of Iranian pharmacy students, (Iran, 1996).

2) S. Shojaiee, Y. Sohrabi, A. Badiee, Effect of Gentamycine on stimulation of immune system in rabbit. Proceeding of the 4th congress of Iranian pharmacy students, (Iran, 1997).

3) H. A. Garekani, F. Sadeghi, A. Badiee, A. R. Rajabi-Siahboomi, Crystal habit modifications of ibuprofen and their physico-mechanical characteristics., 19th Pharmaceutical Technology Conference, (Italy, 2000).

4) A. Badiee, M. R. Jaafari, A. Samiei, D. Soroush, J. Webb, A. Khamesipour, Immunization of BALB/c mice against cutaneous leishmaniasis using liposomes containing rLmSTI1 and CpG ODNs, Third World Congress on Leishmaniosis, (Italy, 2005).

5) M. R. Jaafari, A. Badiee, A. Samiei, D. Soroush, A. Khamesipour, M. Amani, F. Mahboudi, Vaccination of BALB/c mice against cutaneous leishmaniasis using liposomes containing rgp63 and CpG ODNs, Third World Congress on Leishmaniosis, (Italy, 2005, oral presentation).

6) A. Badiee, M. Kato, D. N. J. Hart, N. M. Davies, Uptake of anti DEC205 IgG immunoliposomes by immature and mature dendritic cells: Comparison with control IgG immunoliposomes and conventional liposomes, 33rd Annual Meeting & Exposition of the Controlled Release Society, (Austria, 2006).

7) A. Badiee, M. R. Jaafari, A. Khamesipour, Immunization of BALB/c mice against cutaneous Leishmaniasis by Leishmania major strees inducible protein 1 encapsulated in liposomes,10th Iranian Pharmaceutical Ssciences Conference, (Iran, 2006).

     8) A. Badiee, M. Kato, D. N. J. Hart, N. M. Davies, Enhanced delivery of anti-hDEC-205 immunoliposomes to human dendritic cells: A strategy for DC-based cancer immunotherapy, 19th Asia Pacific Cancer Conference, (Iran, 2007, oral presentation).

                 9) M. R. Jaafari, A. Badiee, A. Samiei, D. Soroush, A. Khamesipour, Enhancement of immune response and protection in BALB/c mice immunized with liposomal recombinant major surface glycoprotein of Leishmania (rgp63): The role of bilayer composition, 3rd ILS Annual Meeting: Liposome Advances, (UK, 2007).

      10) M. R. Jaafari, A. Badiee, A. Samiei, D. Soroush; M. T. Kheiri, F. Barkhordari, A. Khamesipour, F. Mahboudi, The role of liposome charge on immune response generated in BALB/c mice immunized with rgp63, 11th Liposome Research Days Conference, (Japan, 2008).

11) A. Badiee, M. Kato, D. N. J. Hart, N. M. Davies, Preparation and characterization of anti-hDEC-205 immunoliposome nanoparticles for targeting to human dendritic cells, The Specialized Congress And International Exhibition Of Nanomedicine, Nanobiotechnology, Nanobiosensors And Nanomaterials, (Iran, 2009, oral presentation).

12) M.R. Jaafari, A. Badiee,A. Khamesipour, A. Samiei, D Soroush, A Abbasi, M Tavassoti Kheiri, F Barkhordari, F Mahboudi, Immunization of BALB/c Mice against Leishmaniasis using LPD Nanoparticles Containing rgp63 and rLmaCIN Prepared with CpG Oligodeoxynucleotides, The Specialized Congress And International Exhibition Of Nanomedicine, Nanobiotechnology, Nanobiosensors And Nanomaterials, (Iran, 2009).

13) A. M. Eslahtalab, A. Badiee, Dendritic Cells-based Cancer Vaccines: The Role of Lipid-based Nanoparticles, The Specialized Congress And International Exhibition Of Nanomedicine, Nanobiotechnology, Nanobiosensors And Nanomaterials, (Iran, 2009).

14) H. Alavizade, A. Badiee, M. R. Jaafari, Lipid-Protamine-DNA (LPD) Nanoparticles as a Aaccine Delivery System for Cancer Immunotherapy, The Specialized Congress And International Exhibition Of Nanomedicine, Nanobiotechnology, Nanobiosensors And Nanomaterials, (Iran, 2009).

15) M. Amin, A. Badiee, M. R. Jaafari, Nanoparticulate Systems in Cancer Detection and Therapy, The Specialized Congress And International Exhibition Of Nanomedicine, Nanobiotechnology, Nanobiosensors And Nanomaterials, (Iran, 2009).

16) A. Badiee, M. R. Jaafari, A. Khamesipour, Formulation, characterization and evaluation of immune response of liposomes containing leishmania antigen and CpG ODN against leishmaniasis in murine model, 4th Iranian Controlled Release Conference (Iran, 2009, oral presentation).

17) A. H. Alavizadeh, M. R. Jaafari, A. Badiee, A. Khamesipour, A. Jalali, A. Abbasi, Evaluation of lesion development and type of immune response generated in mice inoculated with L. major mixed with LPD Nanoparticles containing CpG ODN, 3rd Conference on Nanotechnology (Iran, 2010, oral presentation)

مقالات دیگر...

  1. Dr. Malaekeh
  2. Dr. Jafari
  3. Dr. Ramezani
 

بازديدكنندگان

امروز: 62
ديروز:40
اين هفته: 407
هفته‌ي گذشته: 429
اين ماه: 1323
ماه گذشته: 1908
افراد آنلاين:1
اعضا ی آنلاین : 0
مهمان آنلاین : 1

اوقات شرعی

دانشگاه علوم پزشکی مشهد | Mashhad University of Medical Sciences | جامعة مشهد للعلوم الطبية
تمام حقوق مادی و معنوی این سایت مربوط به دانشگاه علوم پزشکی مشهد می باشد. هرگونه کپی برداری از مطالب آن تنها با ذکر منبع بلامانع است.